Interestingly, programmed cell death protein-1 (PD-1) as a potent immune inhibitory receptor is well-known in tumor therapy (77), which is also expressed on mouse ILC2s and acts an early checkpoint in ILC2s (78, 79). Here, PDCD1 is linked to neoplasm.